Navigation Links
Medication Review May Help With Heart Failure
Date:8/21/2009

Hospitalizations decline when doctors, pharmacists collaborate, study finds

FRIDAY, Aug. 21 (HealthDay News) -- If doctors and pharmacists work together to ensure that people with heart failure take their medicines correctly, hospitalizations would be less frequent, an Australian study suggests.

In a study of 5,717 people with heart failure, the hospitalization rate for the 273 who had their medications reviewed by doctors and pharmacists was 45 percent lower than the hospitalization rate for the others, whose medicines did not undergo a collaborative review.

People in the study averaged about 82 years old. Those who had their medicines reviewed were slightly sicker and, on average, had more health problems in addition to heart failure than the others -- eight vs. seven.

During a year-long follow-up, 5.5 percent of the people in the medication-review group were hospitalized, compared with 12 percent of those in the no-review group.

The study appears online Aug. 18 in Circulation: Heart Failure.

As part of the review, pharmacists visited the participants at home and asked to see all of their prescription and non-prescription drugs. The pharmacists looked for such signs of possible medication misuse as under-dosing, overdosing and hoarding of unneeded medications from previous prescriptions, which can increase the risk of accidentally taking the wrong medicine. They also looked for over-the-counter medications and vitamins that could interact with prescription drugs.

After reviewing the medications, the pharmacist prepared a report for the person's doctor, who followed up if needed.

A collaborative review system comparable to the one followed in the study has been available in Australia since 2001.

"This is the first study to show these benefits in real-world practice, rather than in a trial setting," the study's lead author, Elizabeth E. Roughead, a pharm
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
2. Manic phase of bipolar disorder benefits from breast cancer medication
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. Mayo Clinic study indicates medication for ADHD may help student outcomes
5. Diet and medications may assist prevention of prostate cancer
6. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
7. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
8. Moses Taylor Hospital Automates Medication Reconciliation
9. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
10. Patients cant recall their medications to tell doctors
11. Patient Empowerment -- Medication Error
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medication Review May Help With Heart Failure
Medication Review May Help With Heart Failure
Breaking Medicine Technology:Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 1Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 2Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 3Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 1Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 2Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8